Report Overview
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer diagnostic technologies provide fast and convenient procedures for noninvasive early detection of cancer and provide a valuable aid to the clinician and increased comfort to the patient.Noninvasive Cancer Diagnosis Technologies are used to identify breast, lung, blood, and other cancers.
The global Noninvasive Cancer Diagnostics Technology market size was estimated at USD 3520 million in 2023 and is projected to reach USD 6636.52 million by 2032, exhibiting a CAGR of 7.30% during the forecast period.
North America Noninvasive Cancer Diagnostics Technology market size was estimated at USD 1035.58 million in 2023, at a CAGR of 6.26% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Noninvasive Cancer Diagnostics Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Cancer Diagnostics Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Cancer Diagnostics Technology market in any manner.
Global Noninvasive Cancer Diagnostics Technology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Precision Therapeutics
Affymetrix Inc.
Gen-Probe Incorporated
AVIVA Biosciences Corporation
A&G Pharmaceutical
BIOVIEW Inc.
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings.
GRAIL
Inc
Guardant Health
Inc
Genomic Health
Inc.
Illumina
Inc
NeoGenomics Laboratories
Inc.
Biocept
Inc
Market Segmentation (by Type)
Immunoassays
Molecular Diagnostics
Clinical Chemistry
Others
Market Segmentation (by Application)
Medical Device Manufacturing Company
Oncology Laboratories
Government and Private Research Institutions
Academic Institutions and Pharmaceutical Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Noninvasive Cancer Diagnostics Technology Market
Overview of the regional outlook of the Noninvasive Cancer Diagnostics Technology Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Noninvasive Cancer Diagnostics Technology
1.2 Key Market Segments
1.2.1 Noninvasive Cancer Diagnostics Technology Segment by Type
1.2.2 Noninvasive Cancer Diagnostics Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Noninvasive Cancer Diagnostics Technology Market Overview
2.1 Global Market Overview
2.1.1 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Noninvasive Cancer Diagnostics Technology Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Noninvasive Cancer Diagnostics Technology Market Competitive Landscape
3.1 Global Noninvasive Cancer Diagnostics Technology Sales by Manufacturers (2019-2025)
3.2 Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Manufacturers (2019-2025)
3.3 Noninvasive Cancer Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Cancer Diagnostics Technology Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Noninvasive Cancer Diagnostics Technology Sales Sites, Area Served, Product Type
3.6 Noninvasive Cancer Diagnostics Technology Market Competitive Situation and Trends
3.6.1 Noninvasive Cancer Diagnostics Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Cancer Diagnostics Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Cancer Diagnostics Technology Industry Chain Analysis
4.1 Noninvasive Cancer Diagnostics Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Cancer Diagnostics Technology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Cancer Diagnostics Technology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Type (2019-2025)
6.3 Global Noninvasive Cancer Diagnostics Technology Market Size Market Share by Type (2019-2025)
6.4 Global Noninvasive Cancer Diagnostics Technology Price by Type (2019-2025)
7 Noninvasive Cancer Diagnostics Technology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Cancer Diagnostics Technology Market Sales by Application (2019-2025)
7.3 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) by Application (2019-2025)
7.4 Global Noninvasive Cancer Diagnostics Technology Sales Growth Rate by Application (2019-2025)
8 Noninvasive Cancer Diagnostics Technology Market Consumption by Region
8.1 Global Noninvasive Cancer Diagnostics Technology Sales by Region
8.1.1 Global Noninvasive Cancer Diagnostics Technology Sales by Region
8.1.2 Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Cancer Diagnostics Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Cancer Diagnostics Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Cancer Diagnostics Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Cancer Diagnostics Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Cancer Diagnostics Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Noninvasive Cancer Diagnostics Technology Market Production by Region
9.1 Global Production of Noninvasive Cancer Diagnostics Technology by Region (2019-2025)
9.2 Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Region (2019-2025)
9.3 Global Noninvasive Cancer Diagnostics Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Noninvasive Cancer Diagnostics Technology Production
9.4.1 North America Noninvasive Cancer Diagnostics Technology Production Growth Rate (2019-2025)
9.4.2 North America Noninvasive Cancer Diagnostics Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Noninvasive Cancer Diagnostics Technology Production
9.5.1 Europe Noninvasive Cancer Diagnostics Technology Production Growth Rate (2019-2025)
9.5.2 Europe Noninvasive Cancer Diagnostics Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Noninvasive Cancer Diagnostics Technology Production (2019-2025)
9.6.1 Japan Noninvasive Cancer Diagnostics Technology Production Growth Rate (2019-2025)
9.6.2 Japan Noninvasive Cancer Diagnostics Technology Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Noninvasive Cancer Diagnostics Technology Production (2019-2025)
9.7.1 China Noninvasive Cancer Diagnostics Technology Production Growth Rate (2019-2025)
9.7.2 China Noninvasive Cancer Diagnostics Technology Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Precision Therapeutics
10.1.1 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Basic Information
10.1.2 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Overview
10.1.3 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Market Performance
10.1.4 Precision Therapeutics Business Overview
10.1.5 Precision Therapeutics Noninvasive Cancer Diagnostics Technology SWOT Analysis
10.1.6 Precision Therapeutics Recent Developments
10.2 Affymetrix Inc.
10.2.1 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Basic Information
10.2.2 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Overview
10.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
10.2.4 Affymetrix Inc. Business Overview
10.2.5 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology SWOT Analysis
10.2.6 Affymetrix Inc. Recent Developments
10.3 Gen-Probe Incorporated
10.3.1 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
10.3.2 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
10.3.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Market Performance
10.3.4 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology SWOT Analysis
10.3.5 Gen-Probe Incorporated Business Overview
10.3.6 Gen-Probe Incorporated Recent Developments
10.4 AVIVA Biosciences Corporation
10.4.1 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Basic Information
10.4.2 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Overview
10.4.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Market Performance
10.4.4 AVIVA Biosciences Corporation Business Overview
10.4.5 AVIVA Biosciences Corporation Recent Developments
10.5 AandG Pharmaceutical
10.5.1 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Basic Information
10.5.2 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Overview
10.5.3 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Market Performance
10.5.4 AandG Pharmaceutical Business Overview
10.5.5 AandG Pharmaceutical Recent Developments
10.6 BIOVIEW Inc.
10.6.1 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Basic Information
10.6.2 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Overview
10.6.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
10.6.4 BIOVIEW Inc. Business Overview
10.6.5 BIOVIEW Inc. Recent Developments
10.7 Quest Diagnostics Incorporated
10.7.1 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
10.7.2 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
10.7.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Market Performance
10.7.4 Quest Diagnostics Incorporated Business Overview
10.7.5 Quest Diagnostics Incorporated Recent Developments
10.8 Digene Corporation
10.8.1 Digene Corporation Noninvasive Cancer Diagnostics Technology Basic Information
10.8.2 Digene Corporation Noninvasive Cancer Diagnostics Technology Product Overview
10.8.3 Digene Corporation Noninvasive Cancer Diagnostics Technology Product Market Performance
10.8.4 Digene Corporation Business Overview
10.8.5 Digene Corporation Recent Developments
10.9 Laboratory Corporation of America Holdings.
10.9.1 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Basic Information
10.9.2 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Overview
10.9.3 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Market Performance
10.9.4 Laboratory Corporation of America Holdings. Business Overview
10.9.5 Laboratory Corporation of America Holdings. Recent Developments
10.10 GRAIL
10.10.1 GRAIL Noninvasive Cancer Diagnostics Technology Basic Information
10.10.2 GRAIL Noninvasive Cancer Diagnostics Technology Product Overview
10.10.3 GRAIL Noninvasive Cancer Diagnostics Technology Product Market Performance
10.10.4 GRAIL Business Overview
10.10.5 GRAIL Recent Developments
10.11 Inc
10.11.1 Inc Noninvasive Cancer Diagnostics Technology Basic Information
10.11.2 Inc Noninvasive Cancer Diagnostics Technology Product Overview
10.11.3 Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
10.11.4 Inc Business Overview
10.11.5 Inc Recent Developments
10.12 Guardant Health
10.12.1 Guardant Health Noninvasive Cancer Diagnostics Technology Basic Information
10.12.2 Guardant Health Noninvasive Cancer Diagnostics Technology Product Overview
10.12.3 Guardant Health Noninvasive Cancer Diagnostics Technology Product Market Performance
10.12.4 Guardant Health Business Overview
10.12.5 Guardant Health Recent Developments
10.13 Inc
10.13.1 Inc Noninvasive Cancer Diagnostics Technology Basic Information
10.13.2 Inc Noninvasive Cancer Diagnostics Technology Product Overview
10.13.3 Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
10.13.4 Inc Business Overview
10.13.5 Inc Recent Developments
10.14 Genomic Health
10.14.1 Genomic Health Noninvasive Cancer Diagnostics Technology Basic Information
10.14.2 Genomic Health Noninvasive Cancer Diagnostics Technology Product Overview
10.14.3 Genomic Health Noninvasive Cancer Diagnostics Technology Product Market Performance
10.14.4 Genomic Health Business Overview
10.14.5 Genomic Health Recent Developments
10.15 Inc.
10.15.1 Inc. Noninvasive Cancer Diagnostics Technology Basic Information
10.15.2 Inc. Noninvasive Cancer Diagnostics Technology Product Overview
10.15.3 Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
10.15.4 Inc. Business Overview
10.15.5 Inc. Recent Developments
10.16 Illumina
10.16.1 Illumina Noninvasive Cancer Diagnostics Technology Basic Information
10.16.2 Illumina Noninvasive Cancer Diagnostics Technology Product Overview
10.16.3 Illumina Noninvasive Cancer Diagnostics Technology Product Market Performance
10.16.4 Illumina Business Overview
10.16.5 Illumina Recent Developments
10.17 Inc
10.17.1 Inc Noninvasive Cancer Diagnostics Technology Basic Information
10.17.2 Inc Noninvasive Cancer Diagnostics Technology Product Overview
10.17.3 Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
10.17.4 Inc Business Overview
10.17.5 Inc Recent Developments
10.18 NeoGenomics Laboratories
10.18.1 NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Basic Information
10.18.2 NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Product Overview
10.18.3 NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Product Market Performance
10.18.4 NeoGenomics Laboratories Business Overview
10.18.5 NeoGenomics Laboratories Recent Developments
10.19 Inc.
10.19.1 Inc. Noninvasive Cancer Diagnostics Technology Basic Information
10.19.2 Inc. Noninvasive Cancer Diagnostics Technology Product Overview
10.19.3 Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
10.19.4 Inc. Business Overview
10.19.5 Inc. Recent Developments
10.20 Biocept
10.20.1 Biocept Noninvasive Cancer Diagnostics Technology Basic Information
10.20.2 Biocept Noninvasive Cancer Diagnostics Technology Product Overview
10.20.3 Biocept Noninvasive Cancer Diagnostics Technology Product Market Performance
10.20.4 Biocept Business Overview
10.20.5 Biocept Recent Developments
10.21 Inc
10.21.1 Inc Noninvasive Cancer Diagnostics Technology Basic Information
10.21.2 Inc Noninvasive Cancer Diagnostics Technology Product Overview
10.21.3 Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
10.21.4 Inc Business Overview
10.21.5 Inc Recent Developments
11 Noninvasive Cancer Diagnostics Technology Market Forecast by Region
11.1 Global Noninvasive Cancer Diagnostics Technology Market Size Forecast
11.2 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country
11.2.3 Asia Pacific Noninvasive Cancer Diagnostics Technology Market Size Forecast by Region
11.2.4 South America Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Cancer Diagnostics Technology by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Noninvasive Cancer Diagnostics Technology by Type (2025-2032)
12.1.2 Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Noninvasive Cancer Diagnostics Technology by Type (2025-2032)
12.2 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Application (2025-2032)
12.2.1 Global Noninvasive Cancer Diagnostics Technology Sales (K Units) Forecast by Application
12.2.2 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Noninvasive Cancer Diagnostics Technology Market Size Comparison by Region (M USD)
Table 5. Global Noninvasive Cancer Diagnostics Technology Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Noninvasive Cancer Diagnostics Technology Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Noninvasive Cancer Diagnostics Technology Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics Technology as of 2022)
Table 10. Global Market Noninvasive Cancer Diagnostics Technology Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Noninvasive Cancer Diagnostics Technology Sales Sites and Area Served
Table 12. Manufacturers Noninvasive Cancer Diagnostics Technology Product Type
Table 13. Global Noninvasive Cancer Diagnostics Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Noninvasive Cancer Diagnostics Technology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Noninvasive Cancer Diagnostics Technology Market Challenges
Table 22. Global Noninvasive Cancer Diagnostics Technology Sales by Type (K Units)
Table 23. Global Noninvasive Cancer Diagnostics Technology Market Size by Type (M USD)
Table 24. Global Noninvasive Cancer Diagnostics Technology Sales (K Units) by Type (2019-2025)
Table 25. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Type (2019-2025)
Table 26. Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) by Type (2019-2025)
Table 27. Global Noninvasive Cancer Diagnostics Technology Market Size Share by Type (2019-2025)
Table 28. Global Noninvasive Cancer Diagnostics Technology Price (USD/Unit) by Type (2019-2025)
Table 29. Global Noninvasive Cancer Diagnostics Technology Sales (K Units) by Application
Table 30. Global Noninvasive Cancer Diagnostics Technology Market Size by Application
Table 31. Global Noninvasive Cancer Diagnostics Technology Sales by Application (2019-2025) & (K Units)
Table 32. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Application (2019-2025)
Table 33. Global Noninvasive Cancer Diagnostics Technology Sales by Application (2019-2025) & (M USD)
Table 34. Global Noninvasive Cancer Diagnostics Technology Market Share by Application (2019-2025)
Table 35. Global Noninvasive Cancer Diagnostics Technology Sales Growth Rate by Application (2019-2025)
Table 36. Global Noninvasive Cancer Diagnostics Technology Sales by Region (2019-2025) & (K Units)
Table 37. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Region (2019-2025)
Table 38. North America Noninvasive Cancer Diagnostics Technology Sales by Country (2019-2025) & (K Units)
Table 39. Europe Noninvasive Cancer Diagnostics Technology Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Noninvasive Cancer Diagnostics Technology Sales by Region (2019-2025) & (K Units)
Table 41. South America Noninvasive Cancer Diagnostics Technology Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Noninvasive Cancer Diagnostics Technology Sales by Region (2019-2025) & (K Units)
Table 43. Global Noninvasive Cancer Diagnostics Technology Production (K Units) by Region (2019-2025)
Table 44. Global Noninvasive Cancer Diagnostics Technology Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Region (2019-2025)
Table 46. Global Noninvasive Cancer Diagnostics Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Noninvasive Cancer Diagnostics Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Noninvasive Cancer Diagnostics Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Noninvasive Cancer Diagnostics Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Noninvasive Cancer Diagnostics Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Basic Information
Table 52. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Overview
Table 53. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Precision Therapeutics Business Overview
Table 55. Precision Therapeutics Noninvasive Cancer Diagnostics Technology SWOT Analysis
Table 56. Precision Therapeutics Recent Developments
Table 57. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Basic Information
Table 58. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Overview
Table 59. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Affymetrix Inc. Business Overview
Table 61. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology SWOT Analysis
Table 62. Affymetrix Inc. Recent Developments
Table 63. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
Table 64. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
Table 65. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology SWOT Analysis
Table 67. Gen-Probe Incorporated Business Overview
Table 68. Gen-Probe Incorporated Recent Developments
Table 69. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Basic Information
Table 70. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Overview
Table 71. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. AVIVA Biosciences Corporation Business Overview
Table 73. AVIVA Biosciences Corporation Recent Developments
Table 74. AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Basic Information
Table 75. AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Overview
Table 76. AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. AandG Pharmaceutical Business Overview
Table 78. AandG Pharmaceutical Recent Developments
Table 79. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Basic Information
Table 80. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Overview
Table 81. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. BIOVIEW Inc. Business Overview
Table 83. BIOVIEW Inc. Recent Developments
Table 84. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
Table 85. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
Table 86. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Quest Diagnostics Incorporated Business Overview
Table 88. Quest Diagnostics Incorporated Recent Developments
Table 89. Digene Corporation Noninvasive Cancer Diagnostics Technology Basic Information
Table 90. Digene Corporation Noninvasive Cancer Diagnostics Technology Product Overview
Table 91. Digene Corporation Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Digene Corporation Business Overview
Table 93. Digene Corporation Recent Developments
Table 94. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Basic Information
Table 95. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Overview
Table 96. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Laboratory Corporation of America Holdings. Business Overview
Table 98. Laboratory Corporation of America Holdings. Recent Developments
Table 99. GRAIL Noninvasive Cancer Diagnostics Technology Basic Information
Table 100. GRAIL Noninvasive Cancer Diagnostics Technology Product Overview
Table 101. GRAIL Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. GRAIL Business Overview
Table 103. GRAIL Recent Developments
Table 104. Inc Noninvasive Cancer Diagnostics Technology Basic Information
Table 105. Inc Noninvasive Cancer Diagnostics Technology Product Overview
Table 106. Inc Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Inc Business Overview
Table 108. Inc Recent Developments
Table 109. Guardant Health Noninvasive Cancer Diagnostics Technology Basic Information
Table 110. Guardant Health Noninvasive Cancer Diagnostics Technology Product Overview
Table 111. Guardant Health Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Guardant Health Business Overview
Table 113. Guardant Health Recent Developments
Table 114. Inc Noninvasive Cancer Diagnostics Technology Basic Information
Table 115. Inc Noninvasive Cancer Diagnostics Technology Product Overview
Table 116. Inc Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Inc Business Overview
Table 118. Inc Recent Developments
Table 119. Genomic Health Noninvasive Cancer Diagnostics Technology Basic Information
Table 120. Genomic Health Noninvasive Cancer Diagnostics Technology Product Overview
Table 121. Genomic Health Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Genomic Health Business Overview
Table 123. Genomic Health Recent Developments
Table 124. Inc. Noninvasive Cancer Diagnostics Technology Basic Information
Table 125. Inc. Noninvasive Cancer Diagnostics Technology Product Overview
Table 126. Inc. Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Inc. Business Overview
Table 128. Inc. Recent Developments
Table 129. Illumina Noninvasive Cancer Diagnostics Technology Basic Information
Table 130. Illumina Noninvasive Cancer Diagnostics Technology Product Overview
Table 131. Illumina Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Illumina Business Overview
Table 133. Illumina Recent Developments
Table 134. Inc Noninvasive Cancer Diagnostics Technology Basic Information
Table 135. Inc Noninvasive Cancer Diagnostics Technology Product Overview
Table 136. Inc Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. Inc Business Overview
Table 138. Inc Recent Developments
Table 139. NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Basic Information
Table 140. NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Product Overview
Table 141. NeoGenomics Laboratories Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. NeoGenomics Laboratories Business Overview
Table 143. NeoGenomics Laboratories Recent Developments
Table 144. Inc. Noninvasive Cancer Diagnostics Technology Basic Information
Table 145. Inc. Noninvasive Cancer Diagnostics Technology Product Overview
Table 146. Inc. Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. Inc. Business Overview
Table 148. Inc. Recent Developments
Table 149. Biocept Noninvasive Cancer Diagnostics Technology Basic Information
Table 150. Biocept Noninvasive Cancer Diagnostics Technology Product Overview
Table 151. Biocept Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. Biocept Business Overview
Table 153. Biocept Recent Developments
Table 154. Inc Noninvasive Cancer Diagnostics Technology Basic Information
Table 155. Inc Noninvasive Cancer Diagnostics Technology Product Overview
Table 156. Inc Noninvasive Cancer Diagnostics Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 157. Inc Business Overview
Table 158. Inc Recent Developments
Table 159. Global Noninvasive Cancer Diagnostics Technology Sales Forecast by Region (2025-2032) & (K Units)
Table 160. Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Noninvasive Cancer Diagnostics Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 162. North America Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Noninvasive Cancer Diagnostics Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 164. Europe Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Noninvasive Cancer Diagnostics Technology Sales Forecast by Region (2025-2032) & (K Units)
Table 166. Asia Pacific Noninvasive Cancer Diagnostics Technology Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Noninvasive Cancer Diagnostics Technology Sales Forecast by Country (2025-2032) & (K Units)
Table 168. South America Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Noninvasive Cancer Diagnostics Technology Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Noninvasive Cancer Diagnostics Technology Sales Forecast by Type (2025-2032) & (K Units)
Table 172. Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Noninvasive Cancer Diagnostics Technology Price Forecast by Type (2025-2032) & (USD/Unit)
Table 174. Global Noninvasive Cancer Diagnostics Technology Sales (K Units) Forecast by Application (2025-2032)
Table 175. Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Noninvasive Cancer Diagnostics Technology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Noninvasive Cancer Diagnostics Technology Market Size (M USD), 2019-2032
Figure 5. Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) (2019-2032)
Figure 6. Global Noninvasive Cancer Diagnostics Technology Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Noninvasive Cancer Diagnostics Technology Market Size by Country (M USD)
Figure 11. Noninvasive Cancer Diagnostics Technology Sales Share by Manufacturers in 2023
Figure 12. Global Noninvasive Cancer Diagnostics Technology Revenue Share by Manufacturers in 2023
Figure 13. Noninvasive Cancer Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Noninvasive Cancer Diagnostics Technology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Noninvasive Cancer Diagnostics Technology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Noninvasive Cancer Diagnostics Technology Market Share by Type
Figure 18. Sales Market Share of Noninvasive Cancer Diagnostics Technology by Type (2019-2025)
Figure 19. Sales Market Share of Noninvasive Cancer Diagnostics Technology by Type in 2023
Figure 20. Market Size Share of Noninvasive Cancer Diagnostics Technology by Type (2019-2025)
Figure 21. Market Size Market Share of Noninvasive Cancer Diagnostics Technology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Noninvasive Cancer Diagnostics Technology Market Share by Application
Figure 24. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Application (2019-2025)
Figure 25. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Application in 2023
Figure 26. Global Noninvasive Cancer Diagnostics Technology Market Share by Application (2019-2025)
Figure 27. Global Noninvasive Cancer Diagnostics Technology Market Share by Application in 2023
Figure 28. Global Noninvasive Cancer Diagnostics Technology Sales Growth Rate by Application (2019-2025)
Figure 29. Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Region (2019-2025)
Figure 30. North America Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Noninvasive Cancer Diagnostics Technology Sales Market Share by Country in 2023
Figure 32. U.S. Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Noninvasive Cancer Diagnostics Technology Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Noninvasive Cancer Diagnostics Technology Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Noninvasive Cancer Diagnostics Technology Sales Market Share by Country in 2023
Figure 37. Germany Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Noninvasive Cancer Diagnostics Technology Sales Market Share by Region in 2023
Figure 44. China Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (K Units)
Figure 50. South America Noninvasive Cancer Diagnostics Technology Sales Market Share by Country in 2023
Figure 51. Brazil Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Noninvasive Cancer Diagnostics Technology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Noninvasive Cancer Diagnostics Technology Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Noninvasive Cancer Diagnostics Technology Production Market Share by Region (2019-2025)
Figure 62. North America Noninvasive Cancer Diagnostics Technology Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Noninvasive Cancer Diagnostics Technology Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Noninvasive Cancer Diagnostics Technology Production (K Units) Growth Rate (2019-2025)
Figure 65. China Noninvasive Cancer Diagnostics Technology Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Noninvasive Cancer Diagnostics Technology Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Noninvasive Cancer Diagnostics Technology Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Noninvasive Cancer Diagnostics Technology Market Share Forecast by Type (2025-2032)
Figure 70. Global Noninvasive Cancer Diagnostics Technology Sales Forecast by Application (2025-2032)
Figure 71. Global Noninvasive Cancer Diagnostics Technology Market Share Forecast by Application (2025-2032)
